1. Home
  2. SLNG vs CGTX Comparison

SLNG vs CGTX Comparison

Compare SLNG & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

N/A

Current Price

$3.72

Market Cap

103.2M

Sector

Utilities

ML Signal

N/A

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.19

Market Cap

110.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
CGTX
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.2M
110.8M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
SLNG
CGTX
Price
$3.72
$1.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$10.00
$3.33
AVG Volume (30 Days)
19.5K
765.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
2400.00
62.79
EPS
N/A
N/A
Revenue
$68,245,000.00
N/A
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.21
$0.24
52 Week High
$6.36
$3.83

Technical Indicators

Market Signals
Indicator
SLNG
CGTX
Relative Strength Index (RSI) 45.18 50.33
Support Level $3.28 $1.02
Resistance Level $3.83 $1.19
Average True Range (ATR) 0.28 0.08
MACD -0.01 -0.01
Stochastic Oscillator 42.22 54.00

Price Performance

Historical Comparison
SLNG
CGTX

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: